PT - JOURNAL ARTICLE AU - Pandolfi, Laura AU - Fossali, Tommaso AU - Frangipane, Vanessa AU - Bozzini, Sara AU - Morosini, Monica AU - D’Amato, Maura AU - Lettieri, Sara AU - Urtis, Mario AU - Di Toro, Alessandro AU - Saracino, Laura AU - Percivalle, Elena AU - Tomaselli, Stefano AU - Cavagna, Lorenzo AU - Cova, Emanuela AU - Mojoli, Francesco AU - Bergomi, Paola AU - Ottolina, Davide AU - Lilleri, Daniele AU - Corsico, Angelo Guido AU - Arbustini, Eloisa AU - Colombo, Riccardo AU - Meloni, Federica TI - Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome AID - 10.1101/2020.07.17.20155978 DP - 2020 Jan 01 TA - medRxiv PG - 2020.07.17.20155978 4099 - http://medrxiv.org/content/early/2020/07/17/2020.07.17.20155978.short 4100 - http://medrxiv.org/content/early/2020/07/17/2020.07.17.20155978.full AB - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly reached pandemic proportions. We conducted a prospective study to assess deep lung inflammatory status in patients with moderate to severe COVID-19.Diagnostic bronchoalveolar lavage (BAL) was performed in 33 adult patients with SARS-CoV-2 infection by real-time PCR on nasopharyngeal swab admitted to the Intensive care unit (ICU) (n=28) and to the Intermediate Medicine Ward (IMW) (n=5). We analyze the differential cell count, ultrastructure of cells and Interleukin(IL)6, 8 and 10 levels.ICU patients showed a marked increase in neutrophils (72%, 60-81), lower lymphocyte (8%, 4-12) and macrophages fractions (17%, 11-27) compared to IMW patients (3%, 2-17, 15%, 6-26 and 74%, 58-90, respectively) (p<0.01). Ultrastructural study from ICU patients showed viral-like particles in cytopathic mononuclear cells however extensive cytopathic damage in all cell lineages. Immunostaining with anti-viral capsid and spike antibodies specifically immunoreacted with BAL cells, mostly cytopathic ones. IL6 and IL8 were significantly higher in ICU patients than in IMW (IL6 p<0.01, IL8 p<0.0001), and also in patients who did not survive (IL6 p < 0.05, IL8 p = 0.05 vs. survivors). IL10 did not show a significant variation between groups. Dividing patients by treatment received, lower BAL concentrations of IL6 were found in patients treated with steroids as compared to those treated with tocilizumab (p<0.1) or antivirals (p<0.05).Alveolitis, associated with COVID-19, is mainly sustained by innate effectors which showed features of extensive activation. The burden of pro-inflammatory cytokines IL6 and IL8 in the broncho-alveolar environment is associated with clinical outcome.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAssociazione Trapiantami un Sorriso; Fondazione Cariplo (COVIM project); Ministry of Health funds to IRCCS Foundation Policlinico San Matteo GrantAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Research and data collection protocols were approved by the Institutional Review Boards (Comitato Etico di Area 1) (prot. 20100005334) and by IRCCS Policlinico San Matteo Foundation Hospital (prot. 20200046007), written informed consent was provided by patients when possible (IMW and conscious ICU patients) and was waived in all other cases.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be available in anonymized form by request to the corresponding author for research purposes, after approval by the institutional ethical committee, and after approval by all co-authors